Clinical Policy: Methylnaltrexone Bromide (Relistor)
Customize your policy alerts
Sign up for Arizona Complete Health Policy AZ.CP.PMN.169 alerts
Get alerted when Policy AZ.CP.PMN.169 changes without checking for updates manually.
Monitor payer policy activity
Arizona Medicaid coverage and prior authorization for Relistor tablets and injection to treat opioid-induced constipation in adults, including initial and continued-therapy requirements, dosing limits, exclusions, and documentation.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.